Celldex Therapeutics, Inc.【CLDX】 業績推移・財務諸表

(単位:千ドル) 2Q11 3Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25 2Q25
売上高 1,952 2,363 2,433 2,009 3,113 3,647 2,414 97 980 620 416 592 1,101 1,477 486 2,178 1,026 1,303 1,389 2,220 1,874 1,534 3,829 3,924 3,456 4,068 2,763 941 1,425 715 546 887 2,728 236 668 3,786 685 3,480 153 174 163 407 967 268 1,517 156 2,498 3,191 695 730
売上成長率(%) - - - - - -
研究開発費 7,169 8,594 10,769 11,114 11,769 - 14,090 15,090 20,417 - 27,070 24,100 26,185 - 25,125 26,490 24,656 27,447 25,711 25,009 - 25,793 24,999 21,915 - 21,875 21,448 11,918 11,151 10,081 11,101 - 11,695 9,705 10,708 - 12,720 12,356 13,557 17,056 20,731 21,572 26,798 26,252 34,535 31,661 39,687 45,263 52,614 54,196
営業費用 11,833 13,841 15,721 15,497 17,864 - 19,815 18,755 24,249 - 31,905 29,141 31,443 - 31,467 34,928 33,397 37,007 33,755 32,213 - 36,646 32,757 35,885 - 123,745 19,636 8,705 19,366 12,972 12,390 - 15,595 11,601 15,010 - 17,324 16,920 20,977 23,431 36,559 28,103 33,438 33,473 42,756 40,764 48,815 55,317 63,434 64,587
営業利益 -9,881 -11,478 -13,288 -13,488 -14,751 - -17,401 -18,658 -23,269 - -31,489 -28,549 -30,342 - -30,981 -32,750 -32,371 -35,704 -32,366 -29,993 - -35,112 -28,928 -31,961 - -119,677 -16,873 -7,764 -17,941 -12,257 -11,844 - -12,867 -11,365 -14,342 - -16,639 -13,440 -20,824 -23,257 -36,396 -27,696 -32,471 -33,205 -41,239 -40,608 -46,317 -52,126 -62,739 -63,857
営業利益率 (%) - - - - - - -
経常(税引前)利益 - - - - - - - - - - - - - - - - - - - - - - - -31,563 - -118,897 -16,407 -7,243 -17,239 -11,779 -11,413 - - -11,259 -14,224 - - -13,373 -20,679 -23,050 -36,004 -26,784 - - - - - - - -
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - - - - - -804.36 - -2922.74 -593.81 -769.71 -1209.75 -1647.41 -2090.29 - - -4770.76 -2129.34 - - -384.28 -13515.69 -13247.13 -22088.34 -6580.84 - - - - - - - -
法人税等合計 - - - - - - - - - - - - - - - - - - - - - - - -5,200 - -765 - - - - - - - -228 - - - - -227 - - - - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -10,236 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -56,600
純利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.49 -0.77 -0.57 -0.62 -0.65 -0.81 -0.56 -0.54 -0.64 -0.81 -0.85
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.49 -0.77 -0.57 -0.62 -0.65 -0.81 -0.56 -0.54 -0.64 -0.81 -0.85
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -